74%
no Admiral Markets Cyprus Ltd. privātajiem ieguldītājiem savos kontos zaudē naudu, veicot CFD tirdzniecību.
Ieguldījumi ir saistīti ar riskiem, un tie var nebūt piemēroti visiem investoriem. CFD ir pietiekami sarežģīti instrumenti, un tiem ir augsts risks attiecībā uz strauju naudas zaudēšanu sviras finansējuma dēļ.
74%
no Admiral Markets Cyprus Ltd. privātajiem ieguldītājiem savos kontos zaudē naudu, veicot CFD tirdzniecību.
Jums būtu jāapsver tas, vai izprotat, kā CFD darbojas, un vai jūs varat atļauties uzņemties augsto naudas zaudēšanas risku.
74%
no Admiral Markets Cyprus Ltd. privātajiem ieguldītājiem savos kontos zaudē naudu, veicot CFD tirdzniecību.
Ieguldījumi ir saistīti ar riskiem, un tie var nebūt piemēroti visiem investoriem. CFD ir pietiekami sarežģīti instrumenti, un tiem ir augsts risks attiecībā uz strauju naudas zaudēšanu sviras finansējuma dēļ.
74%
no Admiral Markets Cyprus Ltd. privātajiem ieguldītājiem savos kontos zaudē naudu, veicot CFD tirdzniecību.
Jums būtu jāapsver tas, vai izprotat, kā CFD darbojas, un vai jūs varat atļauties uzņemties augsto naudas zaudēšanas risku.
M Medical Transcription Billing Corp
M
Slēgts
0
Pārskats
Akcijas cenas izmaiņa
24h
Min
Max
Ienākumi | 1.2M 2.9M |
|---|---|
Pārdošana | 3.4M 34M |
P/E Sektora vidējais | 33.056 66.418 |
Peļņas marža | 8.39 |
Darbinieki | 3,650 |
Rekomendācijas | Pirkt |
|---|---|
Prognoze 12 mēnešiem | +101.07% upside |
Tirgus kapitalizācija | 21M 132M |
|---|---|
Iepriekšējā atvēršanas cena | 0 |
Iepriekšējā slēgšanas cena | 0 |
Medical Transcription Billing Corp Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Saistītās ziņas
Salīdzinājums
Cenas izmaiņa
Medical Transcription Billing Corp Prognoze
Cenas mērķis
By TipRanks
101.07% augšup
Prognoze 12 mēnešiem
Vidējais 5.63 USD 101.07%
Augstākais 8 USD
Zemākais 3.25 USD
Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Medical Transcription Billing Corp — pēdējo 3 mēnešu laikā.
Finanšu rādītāji
$
Par Medical Transcription Billing Corp
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services. Its technology-enabled business solutions comprise revenue cycle management services, healthcare claims clearinghouse, and medical coding and credentialing services; electronic health records, practice management software and related capabilities, patient experience management solutions, business intelligence and healthcare analytics platforms, and customized applications, interfaces, and various other technology solutions, as well as artificial intelligence, such as CareCloud cirrusAI, AI-powered clinical decision support, AI-powered virtual support assistant, AI-driven appeals, and CareCloud cirrusAI. In addition, the company provides chronic care management, remote patient monitoring, and telemedicine solutions; and professional and consulting services, workforce augmentation and on-demand staffing, and strategic advisory services. Further, it offers medical practice management services to medical practices comprising appropriate facilities, equipment, supplies, support services, nurses, and administrative support staff, as well as management, bill-paying, and financial advisory services. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.
Live chat